Loading clinical trials...
Loading clinical trials...
This open-label, multi-center study will evaluate the safety and tolerability and the effect on viral activity of a combined PEGASYS and COPEGUS extended therapy in patients with chronic hepatitis C w...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hoffmann-La Roche
NCT05870969 · Carcinoma, Hepatocellular, Hepatitis C, Chronic, and more
NCT03200379 · Hepatitis C, Chronic
NCT03155906 · Hepatitis C, Chronic, Opioid Dependence, on Agonist Therapy
NCT03987503 · Hepatitis C, Chronic
NCT05397067 · Hepatitis C, Chronic, Substance Use Disorders
Haemek Hospital; Gastroenterology
Afula
Clalit City Ashdod MC; Liver Clinic
Ashdod
Batyamon; Liver Unit
Bat Yam
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions